A Study To Assess The Safety Of PF-06342674 In Adults With Type 1 Diabetes

NCT02038764 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Placebo
BIOLOGICAL: PF-06342674 Dose A
BIOLOGICAL: PF-06342674 Dose B
BIOLOGICAL: PF-06342674 Dose C
BIOLOGICAL: PF-06342674 Dose D

Sponsor

Pfizer